nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclobenzaprine—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.258	0.612	CbGbCtD
Cyclobenzaprine—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.164	0.389	CbGbCtD
Cyclobenzaprine—Swollen tongue—Cyclosporine—focal segmental glomerulosclerosis	0.042	0.0775	CcSEcCtD
Cyclobenzaprine—HTR2A—arteriole—focal segmental glomerulosclerosis	0.0242	0.695	CbGeAlD
Cyclobenzaprine—Cerebration impaired—Cyclosporine—focal segmental glomerulosclerosis	0.021	0.0387	CcSEcCtD
Cyclobenzaprine—Libido increased—Cyclosporine—focal segmental glomerulosclerosis	0.0203	0.0374	CcSEcCtD
Cyclobenzaprine—Tongue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.017	0.0313	CcSEcCtD
Cyclobenzaprine—Cholestasis—Cyclosporine—focal segmental glomerulosclerosis	0.0163	0.03	CcSEcCtD
Cyclobenzaprine—Acne—Cyclosporine—focal segmental glomerulosclerosis	0.0147	0.0271	CcSEcCtD
Cyclobenzaprine—Disturbance in attention—Cyclosporine—focal segmental glomerulosclerosis	0.0143	0.0263	CcSEcCtD
Cyclobenzaprine—Nightmare—Cyclosporine—focal segmental glomerulosclerosis	0.0119	0.022	CcSEcCtD
Cyclobenzaprine—Gynaecomastia—Cyclosporine—focal segmental glomerulosclerosis	0.0111	0.0204	CcSEcCtD
Cyclobenzaprine—Mental disability—Cyclosporine—focal segmental glomerulosclerosis	0.0107	0.0198	CcSEcCtD
Cyclobenzaprine—Hepatic function abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.0103	0.0189	CcSEcCtD
Cyclobenzaprine—Vascular purpura—Cyclosporine—focal segmental glomerulosclerosis	0.01	0.0185	CcSEcCtD
Cyclobenzaprine—Disorientation—Cyclosporine—focal segmental glomerulosclerosis	0.01	0.0185	CcSEcCtD
Cyclobenzaprine—Libido decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00967	0.0178	CcSEcCtD
Cyclobenzaprine—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00931	0.0172	CcSEcCtD
Cyclobenzaprine—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00897	0.0165	CcSEcCtD
Cyclobenzaprine—Disturbance in sexual arousal—Cyclosporine—focal segmental glomerulosclerosis	0.0089	0.0164	CcSEcCtD
Cyclobenzaprine—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.00794	0.0146	CcSEcCtD
Cyclobenzaprine—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.0072	0.0133	CcSEcCtD
Cyclobenzaprine—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.00716	0.0132	CcSEcCtD
Cyclobenzaprine—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.00706	0.013	CcSEcCtD
Cyclobenzaprine—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.00681	0.0126	CcSEcCtD
Cyclobenzaprine—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.00678	0.0125	CcSEcCtD
Cyclobenzaprine—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.00678	0.0125	CcSEcCtD
Cyclobenzaprine—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00674	0.0124	CcSEcCtD
Cyclobenzaprine—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.00674	0.0124	CcSEcCtD
Cyclobenzaprine—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00621	0.0114	CcSEcCtD
Cyclobenzaprine—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00617	0.0114	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.00616	0.0114	CcSEcCtD
Cyclobenzaprine—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00579	0.0107	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00554	0.0102	CcSEcCtD
Cyclobenzaprine—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.00548	0.0101	CcSEcCtD
Cyclobenzaprine—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.00532	0.00981	CcSEcCtD
Cyclobenzaprine—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.0053	0.00977	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.00529	0.00975	CcSEcCtD
Cyclobenzaprine—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00525	0.00967	CcSEcCtD
Cyclobenzaprine—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00509	0.00938	CcSEcCtD
Cyclobenzaprine—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00506	0.00933	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00501	0.00924	CcSEcCtD
Cyclobenzaprine—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00496	0.00915	CcSEcCtD
Cyclobenzaprine—HTR2A—endothelium—focal segmental glomerulosclerosis	0.00495	0.143	CbGeAlD
Cyclobenzaprine—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.00494	0.0091	CcSEcCtD
Cyclobenzaprine—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00487	0.00898	CcSEcCtD
Cyclobenzaprine—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00485	0.00895	CcSEcCtD
Cyclobenzaprine—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00484	0.00891	CcSEcCtD
Cyclobenzaprine—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00468	0.00863	CcSEcCtD
Cyclobenzaprine—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00466	0.0086	CcSEcCtD
Cyclobenzaprine—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.0046	0.00848	CcSEcCtD
Cyclobenzaprine—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.0046	0.00848	CcSEcCtD
Cyclobenzaprine—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00458	0.00845	CcSEcCtD
Cyclobenzaprine—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00454	0.00837	CcSEcCtD
Cyclobenzaprine—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.0045	0.00829	CcSEcCtD
Cyclobenzaprine—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00445	0.00819	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.00441	0.00813	CcSEcCtD
Cyclobenzaprine—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00441	0.00813	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00432	0.00796	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00426	0.00786	CcSEcCtD
Cyclobenzaprine—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.0042	0.00775	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00402	0.0074	CcSEcCtD
Cyclobenzaprine—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00399	0.00735	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00396	0.0073	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00393	0.00724	CcSEcCtD
Cyclobenzaprine—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00392	0.00722	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00388	0.00715	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00383	0.00706	CcSEcCtD
Cyclobenzaprine—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.0038	0.00701	CcSEcCtD
Cyclobenzaprine—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00377	0.00695	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00363	0.0067	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.0036	0.00664	CcSEcCtD
Cyclobenzaprine—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.0035	0.00646	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00348	0.00642	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00325	0.00599	CcSEcCtD
Cyclobenzaprine—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00316	0.00583	CcSEcCtD
Cyclobenzaprine—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00312	0.00575	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00302	0.00556	CcSEcCtD
Cyclobenzaprine—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00292	0.00537	CcSEcCtD
Cyclobenzaprine—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.0028	0.00517	CcSEcCtD
Cyclobenzaprine—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00278	0.00512	CcSEcCtD
Cyclobenzaprine—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00278	0.00512	CcSEcCtD
Cyclobenzaprine—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00276	0.00509	CcSEcCtD
Cyclobenzaprine—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00262	0.00483	CcSEcCtD
Cyclobenzaprine—HTR2A—kidney—focal segmental glomerulosclerosis	0.00199	0.0574	CbGeAlD
Cyclobenzaprine—CYP3A4—kidney—focal segmental glomerulosclerosis	0.00185	0.0531	CbGeAlD
Cyclobenzaprine—CYP2D6—kidney—focal segmental glomerulosclerosis	0.00182	0.0523	CbGeAlD
